Back

The EGF/EGFR-YAP1/TEAD2 axis-mediated BRAF inhibitor vemurafenib resistance upregulates STIM1 in melanoma

Bai, W.; Yan, C.; Yang, Y.; Sang, L.; Hao, Q.; Yao, X.; Yu, J.; Wang, Y.; Li, X.; Meng, M.; Yang, J.; Shen, J.; Sun, Y.; Sun, J.

2024-01-29 cancer biology
10.1101/2024.01.29.577717 bioRxiv
Show abstract

STIM1 is the endoplasmic reticulum (ER) Ca2+ sensor for store-operated entry (SOCE) and closely correlated to carcinogenesis and tumor progression. Previously we found that STIM1 is upregulated in melanoma cells resistant to the BRAF inhibitor vemurafenib, but the regulation mechanism is unknown. Here, we show that vemurafenib resistance upregulates STIM1 through an EGF/EGFR-YAP1/TEAD2 axis. Vemurafenib resistance can lead to the increase of EGF and EGFR levels to activate the EGFR signaling pathway. Reactivated EGFR signal promotes YAP1 nuclear localization to increase the expression of STIM1. Our finding not only demonstrates the mechanism by which vemurafenib resistance promotes STIM1 expression, but also provides combined targeting EGF/EGFR-YAP1/TEAD2-STIM1 to improve the therapeutic efficiency of BRAF inhibitor in melanoma patients.

Matching journals

The top 15 journals account for 50% of the predicted probability mass.

1
PLOS ONE
● 5266 papers in training set
Top 15%
12.0%
Similar papers in this journal
2
Frontiers in Oncology
○ 103 papers in training set
Top 0.8%
4.4%
Similar papers in this journal
3
Translational Oncology
○ 21 papers in training set
Top 0.1%
4.4%
Similar papers in this journal
4
eLife
● 5828 papers in training set
Top 30%
4.1%
Similar papers in this journal
5
International Journal of Molecular Sciences
○ 494 papers in training set
Top 4%
3.3%
Similar papers in this journal
6
Scientific Reports
○ 3612 papers in training set
Top 31%
3.3%
7
Heliyon
○ 152 papers in training set
Top 2%
2.8%
8
Biochemistry and Biophysics Reports
○ 30 papers in training set
Top 0.1%
2.8%
9
Bioscience Reports
● 27 papers in training set
Top 0.4%
2.5%
10
Experimental Cell Research
○ 28 papers in training set
Top 0.1%
2.5%
11
Medicine
○ 31 papers in training set
Top 0.6%
2.1%
12
Life Sciences
○ 27 papers in training set
Top 0.3%
2.1%
13
Cellular Signalling
○ 14 papers in training set
Top 0.1%
1.9%
14
Acta Biochimica et Biophysica Sinica
● 23 papers in training set
Top 0.2%
1.7%
15
Cancer Medicine
○ 26 papers in training set
Top 0.5%
1.7%
50% of probability mass above
16
Genes to Cells
○ 25 papers in training set
Top 0.2%
1.7%
17
Gene
○ 46 papers in training set
Top 0.8%
1.7%
18
Cancers
○ 213 papers in training set
Top 3%
1.7%
19
Cell Cycle
○ 17 papers in training set
Top 0.2%
1.5%
20
Aging
○ 75 papers in training set
Top 1.0%
1.4%
21
Cells
○ 249 papers in training set
Top 4%
1.4%
22
PeerJ
◐ 308 papers in training set
Top 6%
1.4%
23
Molecular and Cellular Biology
○ 47 papers in training set
Top 0.5%
1.3%
24
Biochemical and Biophysical Research Communications
○ 84 papers in training set
Top 1%
1.3%
25
Cell Death & Disease
147 papers in training set
Top 2%
1.2%
26
Frontiers in Genetics
○ 230 papers in training set
Top 4%
1.1%
27
BMC Cancer
○ 67 papers in training set
Top 1%
1.1%
28
BioMed Research International
○ 28 papers in training set
Top 1%
1.1%
29
Biomedicines
○ 67 papers in training set
Top 2%
1.1%
30
Journal of Translational Medicine
○ 57 papers in training set
Top 1%
1.1%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.